Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
Peer Reviewed
See detailESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).
Regitz-Zagrosek, Vera; Blomstrom Lundqvist, Carina; Borghi, Claudio et al

in European Heart Journal (2011), 32(24), 3147-97

Detailed reference viewed: 37 (2 ULg)
Full Text
Peer Reviewed
See detailESC working group on valvular heart disease position paper-heart valve clinics: organization, structure, and experiences
LANCELLOTTI, Patrizio ULg; Rosenhek, R; Pibarot, P et al

in European Heart Journal (2013)

Detailed reference viewed: 53 (11 ULg)
Full Text
Peer Reviewed
See detailESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Catapano, Alberico L; Reiner, Zeljko; De Backer, Guy et al

in Atherosclerosis (2011), 217(1), 3-46

Detailed reference viewed: 28 (0 ULg)
Full Text
Peer Reviewed
See detailESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Reiner, Zeljko; Catapano, Alberico L; De Backer, Guy et al

in European Heart Journal (2011), 32(14), 1769-818

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years (DALYs) in Europe, and ... [more ▼]

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years (DALYs) in Europe, and is also increasingly common in developing countries.1 In the European Union, the economic cost of CVD represents annually E192 billion1 in direct and indirect healthcare costs. The main clinical entities are coronary artery disease (CAD), ischaemic stroke, and peripheral arterial disease (PAD). The causes of these CVDs are multifactorial. Some of these factors relate to lifestyles, such as tobacco smoking, lack of physical activity, and dietary habits, and are thus modifiable. Other risk factors are also modifiable, such as elevated blood pressure, type 2 diabetes, and dyslipidaemias, or non-modifiable, such as age and male gender. These guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention. Prevention and treatment of dyslipidaemias should always be considered within the broader framework of CVD prevention, which is addressed in guidelines of the Joint European Societies' Task forces on CVD prevention in clinical practice.2 - 5 The latest version of these guidelines was published in 20075; an update will become available in 2012. These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians [e.g. general practitioners (GPs) and cardiologists] interested in CVD prevention, but also specialists from lipid clinics or metabolic units who are dealing with dyslipidaemias that are more difficult to classify and treat. [less ▲]

Detailed reference viewed: 49 (0 ULg)
See detailL’escalier dans la principauté de Liège au XVIIIe siècle
Paquet, Pierre ULg

in Maisons d’Hier et d’Aujourd’hui (1988), 80

Description of some beautiful staircases in principality of Liège in the XVIIIth century.

Detailed reference viewed: 62 (4 ULg)
Full Text
Peer Reviewed
See detailEscape into Innocence: Ian McEwan and the Nightmare of History
Delrez, Marc ULg

in Ariel : A Review of International English Literature (1995), 26(2), 7-23

Detailed reference viewed: 109 (13 ULg)
Full Text
Peer Reviewed
See detailEscapement Success And Patterns Of Downstream Migration Of Female Silver Eel Anguilla Anguilla In The River Meuse
Verbiest, Hilde; Breukelaar, André; Ovidio, Michaël ULg et al

Poster (2012, May)

Downstream migration of female silver eel Anguilla anguilla (L.) was studied by remote telemetry in the lower part of the River Meuse (Belgium and The Netherlands) using a combination of 9 detection ... [more ▼]

Downstream migration of female silver eel Anguilla anguilla (L.) was studied by remote telemetry in the lower part of the River Meuse (Belgium and The Netherlands) using a combination of 9 detection stations and manual tracking. N=31 eels (LT 64-90cm) were implanted with active transponders and released in 2007 into the River Berwijn, a small Belgian tributary of the River Meuse, 326 km from the North Sea. From August 2007 till April 2008 13 eels (42%) started their downstream migration and were detected at two or more stations. Mean migration speed was 0.62 m.s-1 (or 53 km.day-1). Only two eels (15%) arrived at the North Sea, the others being held up or killed at hydroelectric power stations, caught by fishermen or by predators or stopped their migration and settled in the river delta. A majority (58%) of the eels classified as potential migrants did not start their migration and settled in the River Berwijn or upper Meuse as verified by additional manual tracking. [less ▲]

Detailed reference viewed: 22 (4 ULg)
Full Text
Peer Reviewed
See detailEscapement success and patterns of downstream migration of female silver eel Anguilla anguilla in the River Meuse
Verbiest, Hilde; Breukelaar, André; Ovidio, Michaël ULg et al

in Ecology of Freshwater Fish (2012), 21

Detailed reference viewed: 68 (11 ULg)
See detailEschatologies apocalyptique et millénaristes : christianisme et fin des temps
Delfosse, Annick ULg

Article for general public (2012)

Detailed reference viewed: 48 (11 ULg)
Full Text
Peer Reviewed
See detailEscherichia coli fusion carrier proteins act as solubilizing agents for recombinant uncoupling protein 1 through interactions with GroEL.
Douette, P.; Navet, R.; Gerkens, P. et al

in Biochemical and Biophysical Research Communications (2005), 333

Fusing recombinant proteins to highly soluble partners is frequently used to prevent aggregation of recombinant proteins in Escherichia coli. Moreover, co-overexpression of prokaryotic chaperones can ... [more ▼]

Fusing recombinant proteins to highly soluble partners is frequently used to prevent aggregation of recombinant proteins in Escherichia coli. Moreover, co-overexpression of prokaryotic chaperones can increase the amount of properly folded recombinant proteins. To understand the solubility enhancement of fusion proteins, we designed two recombinant proteins composed of uncoupling protein 1 (UCP1), a mitochondrial membrane protein, in fusion with MBP or NusA. We were able to express soluble forms of MBP-UCP1 and NusA-UCP1 despite the high hydrophobicity of UCP1. Furthermore, the yield of soluble fusion proteins depended on co-overexpression of GroEL that catalyzes folding of polypeptides. MBP-UCP1 was expressed in the form of a non-covalent complex with GroEL. MBP-UCP1/GroEL was purified and characterized by dynamic light scattering, gel filtration, and electron microscopy. Our findings suggest that MBP and NusA act as solubilizing agents by forcing the recombinant protein to pass through the bacterial chaperone pathway in the context of fusion protein. [less ▲]

Detailed reference viewed: 13 (6 ULg)
Peer Reviewed
See detailEscherichia coli in domestic mammals and birds.
Mainil, Jacques ULg; Fairbrother, John

in Morabito, Stefano (Ed.) Pathogenic Escherichia coli : Molecular and cellular microbiology (2014)

Detailed reference viewed: 10 (4 ULg)
Peer Reviewed
See detailEscherichia coli producing CNF1 and CNF2 cytotoxins in animals with different disorders
Pohl, P.; Oswald, E.; Van Muylem, K. et al

in Veterinary Research (1993), 24

Detailed reference viewed: 6 (0 ULg)
Full Text
Peer Reviewed
See detailLes Escherichia coli producteurs de shigatoxines dans les toxi-infections d'origine alimentaire.
Chahed, A.; China, B.; Daube, Georges ULg

in Annales de Médecine Vétérinaire (2007), 151

Certains Escherichia coli producteurs de Shigatoxines (STEC) sont responsables de toxi-infections d’origine alimentaire qui se traduisent par des diarrhées mais aussi par des syndromes plus graves pour ... [more ▼]

Certains Escherichia coli producteurs de Shigatoxines (STEC) sont responsables de toxi-infections d’origine alimentaire qui se traduisent par des diarrhées mais aussi par des syndromes plus graves pour l’homme comme le syndrome hémolytique urémique pouvant provoquer la mort. Il s’agit d’agents zoonotiques dont le réservoir principal est le bovin et les autres ruminants. Les principaux modes de transmission des infections à STEC à l’homme sont la consommation d’aliments contaminés (viande de boeuf peu cuite, produits laitiers non pasteurisés), la transmission de personne à personne, l’ingestion d’eau contaminée et le contact avec des animaux (notamment les bovins) et leur environnement. Les facteurs de virulence des Escherichia coli producteurs de Shigatoxines sont principalement les protéines codées par un îlot de pathogénicité, « Locus of Enterocyte Effacement », impliquées dans la formation de la lésion d’attachement et d’effacement et de la diarrhée et les toxines de Shiga codées par des bactériophages et impliquées dans les syndromes extraintestinaux. La souche de STEC du sérotype O157:H7 est responsable d’épidémies dans le monde causant des milliers de malades et des dizaines de morts. De nombreuses méthodes de diagnostic ont été développées pour identifier ce pathogène à partir des aliments. Elles regroupent des méthodes de bactériologie classique, des méthodes immunologiques et des méthodes moléculaires. Des mesures d’hygiène sont particulièrement importantes pour éviter la contamination des animaux à la ferme et celle de la viande à l’abattoir. Enfin, des modèles d’évaluation du risque ont été développés notamment afin de modéliser le comportement des STEC dans l’aliment. [less ▲]

Detailed reference viewed: 141 (8 ULg)
Peer Reviewed
See detailEscherichia coli productrices de la toxine cytotoxique nécrosante de type 1 (CNF1) isolées à partir de processus pathologiques chez des chats et des chiens
Pohl, P.; Mainil, Jacques ULg; Devriese, L. et al

in Annales de Médecine Vétérinaire (1993), 137

Detailed reference viewed: 16 (0 ULg)